Patents by Inventor James R. Moore

James R. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002162
    Abstract: In various aspects and embodiments the system described herein provides a novel robotic culling system employing a plurality of sorting and orienting robotic systems to cull a moving package stream. A wide variety of embodiments and uses may be employed implementing the apparatus and system utilizing a variety of structures without departing from the teachings of this specification.
    Type: Application
    Filed: July 1, 2022
    Publication date: January 4, 2024
    Inventor: James R Moore, II
  • Patent number: 11204347
    Abstract: A test device for testing of an oxygen sensor uses a compressor to draw air from an external environment and deliver compressed air into a gas separation unit. A gas separation membrane is located in a passage of the gas separation unit such that compressed air from the compressor travels through the passage and passes through the gas separation membrane. The gas separation membrane separates at least one of nitrogen and oxygen from the compressed air to produce a calibration gas having a calibrated amount of oxygen that is different from an amount of oxygen in the air. The calibration gas coupling is configured to be fluidly connected to the oxygen sensor such that the calibration gas is deliverable from the calibration gas coupling to the oxygen sensor.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: December 21, 2021
    Inventors: Ferrel D. Moore, James R. Moore
  • Publication number: 20200300826
    Abstract: A test device for testing of an oxygen sensor uses a compressor to draw air from an external environment and deliver compressed air into a gas separation unit. A gas separation membrane is located in a passage of the gas separation unit such that compressed air from the compressor travels through the passage and passes through the gas separation membrane. The gas separation membrane separates at least one of nitrogen and oxygen from the compressed air to produce a calibration gas having a calibrated amount of oxygen that is different from an amount of oxygen in the air. The calibration gas coupling is configured to be fluidly connected to the oxygen sensor such that the calibration gas is deliverable from the calibration gas coupling to the oxygen sensor.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 24, 2020
    Inventors: Ferrel D. Moore, James R. Moore
  • Patent number: 9790891
    Abstract: A Stirling engine power generation system comprises a first gas fired Stirling engine driving a scroll compressor to provide heat to a second Stirling engine powered generator. The second Stirling engine is partially submersed in a heat transfer medium that is heated by heat transfer fluid compressed by the Stirling scroll compressor and excess heat from gas firing. The invention further comprises a cam drive system with spherical cam followers, and multiple electrical generators.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: October 17, 2017
    Inventor: James R. Moore, II
  • Publication number: 20150313883
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.
    Type: Application
    Filed: July 10, 2015
    Publication date: November 5, 2015
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Patent number: 9107915
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: August 18, 2015
    Assignee: Targacept, Inc.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Publication number: 20140288132
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.
    Type: Application
    Filed: June 5, 2014
    Publication date: September 25, 2014
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Patent number: 8833381
    Abstract: A decorating tip cleaning apparatus includes a first frame member having opposed front and rear edges and a second frame member having opposed front and rear edges. The rear edges of the frame members are pivotally coupled together such that the first and the second frame members are movable between a closed configuration at which the front edges, respectively, are generally adjacent one another and an open configuration at which the front edges, respectively, are separated from one another. The first and second frame members include a mesh material extending between respective front and rear edges. The mesh material of the first frame member defines a plurality of apertures spaced apart from one another, each aperture being configured to receive a decorating tip partially therethrough. Each aperture is configured to receive only a portion of a respective decorating tip.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: September 16, 2014
    Inventor: James R. Moore
  • Patent number: 8778978
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: July 15, 2014
    Assignee: Targacept, Inc.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Publication number: 20140039014
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Application
    Filed: October 3, 2013
    Publication date: February 6, 2014
    Applicant: Targacept, Inc.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Publication number: 20130318736
    Abstract: A decorating tip cleaning apparatus includes a first frame member having opposed front and rear edges and a second frame member having opposed front and rear edges. The rear edges of the frame members are pivotally coupled together such that the first and the second frame members are movable between a closed configuration at which the front edges, respectively, are generally adjacent one another and an open configuration at which the front edges, respectively, are separated from one another. The first and second frame members include a mesh material extending between respective front and rear edges. The mesh material of the first frame member defines a plurality of apertures spaced apart from one another, each aperture being configured to receive a decorating tip partially therethrough. Each aperture is configured to receive only a portion of a respective decorating tip.
    Type: Application
    Filed: May 31, 2012
    Publication date: December 5, 2013
    Inventor: James R. Moore
  • Patent number: 8580826
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: November 12, 2013
    Assignee: Targacept, Inc.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Publication number: 20120041033
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Application
    Filed: October 26, 2011
    Publication date: February 16, 2012
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Publication number: 20120000194
    Abstract: A Stirling engine power generation system comprises a first gas fired Stirling engine driving a scroll compressor to provide heat to a second Stirling engine powered generator. The second Stirling engine is partially submersed in a heat transfer medium that is heated by heat transfer fluid compressed by the Stirling scroll compressor and excess heat from gas firing. The invention further comprises a cam drive system with spherical cam followers, and multiple electrical generators.
    Type: Application
    Filed: June 30, 2011
    Publication date: January 5, 2012
    Inventor: James R. Moore, II
  • Patent number: 8053451
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Grant
    Filed: November 4, 2008
    Date of Patent: November 8, 2011
    Assignee: Targacept, Inc.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Patent number: 7865380
    Abstract: System and process for managing an IT infrastructure which collects transaction information on a component basis. The transaction data is used to evaluate the contribution of each component of the system as well as the business value of the service, and for the infrastructure as a whole. The usage data is prepared as reports and used in an IT management workflow model to make decisions about such things as the timing of system upgrades, strategic architectural decisions, timing of sunsetting of service components, both hardware and software, and the return-on-investment (ROI) valuation of IT investments. Component values may be assessed on either a volume (number of transactions) basis, or on the discrete dollar value of the transactions supported by the component.
    Type: Grant
    Filed: November 8, 2001
    Date of Patent: January 4, 2011
    Assignee: International Business Machines Corporation
    Inventors: L. Mark Ernest, Christopher Finden-Browne, James R. Moore
  • Publication number: 20090062321
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Application
    Filed: November 4, 2008
    Publication date: March 5, 2009
    Applicant: TARGACEPT, INC.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Patent number: 7459469
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: December 2, 2008
    Assignee: Targacept, Inc.
    Inventors: Julio A. Munoz, John Genus, James R. Moore
  • Publication number: 20080249142
    Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.
    Type: Application
    Filed: June 19, 2008
    Publication date: October 9, 2008
    Applicant: Targacept, Inc.
    Inventors: Gary Maurice Dull, Julio A. Munoz, John Genus, James R. Moore
  • Patent number: D652271
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: January 17, 2012
    Assignee: Molenaar, LLC
    Inventors: James R. Moore, Ronald E. Markfelder